DHT.UN Stock Overview
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
DRI Healthcare Trust Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$17.00 |
| 52 Week High | CA$17.43 |
| 52 Week Low | CA$7.55 |
| Beta | 0.92 |
| 1 Month Change | 7.39% |
| 3 Month Change | 30.47% |
| 1 Year Change | 116.56% |
| 3 Year Change | 81.04% |
| 5 Year Change | n/a |
| Change since IPO | 36.55% |
Recent News & Updates
Shareholder Returns
| DHT.UN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -0.9% | -3.6% | -2.1% |
| 1Y | 116.6% | 58.0% | 3.6% |
Return vs Industry: DHT.UN exceeded the Canadian Pharmaceuticals industry which returned 46% over the past year.
Return vs Market: DHT.UN exceeded the Canadian Market which returned 3.2% over the past year.
Price Volatility
| DHT.UN volatility | |
|---|---|
| DHT.UN Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 14.2% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: DHT.UN's share price has been volatile over the past 3 months.
Volatility Over Time: DHT.UN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | n/a | Behzad Khosrowshahi | www.dricapital.com |
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
DRI Healthcare Trust Fundamentals Summary
| DHT.UN fundamental statistics | |
|---|---|
| Market cap | CA$976.12m |
| Earnings (TTM) | CA$127.43m |
| Revenue (TTM) | CA$229.56m |
7.5x
P/E Ratio4.2x
P/S RatioIs DHT.UN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHT.UN income statement (TTM) | |
|---|---|
| Revenue | US$166.28m |
| Cost of Revenue | US$0 |
| Gross Profit | US$166.28m |
| Other Expenses | US$73.98m |
| Earnings | US$92.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
| Earnings per share (EPS) | 1.64 |
| Gross Margin | 100.00% |
| Net Profit Margin | 55.51% |
| Debt/Equity Ratio | 42.5% |
How did DHT.UN perform over the long term?
See historical performance and comparison